Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction [Corrigendum]

Abstract

Ramphul M, Lo DKH, Gaillard EA. J Asthma Allergy. 2021;14:525–538. The authors have advised that Figures 1 and 2 on pages 528 and 533, respectively are in the reverse order. In the original article, Figure 1 appears as Figure 2, and Figure 2 as Figure 1. The Figures with the correct captions are shown in Download Article. The authors apologize for this error. Read the original article

Keywords

• child
• omalizumab
• mepolizumab
• reslizumab
• benralizumab
• dupilumab